Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Proscia study – AI can predict diagnostic concordance for melanoma

By Author Proscia | November 1, 2022

In addition to this study, Proscia plans to conduct additional research illustrating the potential benefits of AI in helping pathologists to diagnose melanoma, including lowering the misdiagnosis rate, accelerating turnaround times for critical results, reducing costs and distress for patients.

Our website uses cookies. By using this site, you agree to its use of cookies.